Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology Class A Ordinary Shares (NNNN) Stock Overview
Explore Anbio Biotechnology Class A Ordinary Shares’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.1B
P/E Ratio
401.87
EPS (TTM)
$0.06
ROE
0.11%
NNNN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Anbio Biotechnology Class A Ordinary Shares (NNNN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 57.63, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $53.77.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 401.87 and a market capitalization of 1.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.